Who Owns ADMA Biologics Stock?
NASDAQ: ADMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 92.78%
- Held by insiders
- 1.97%
- Institutional holders
- 438
- Institutions 92.8%
- Insiders 2.0%
- Public and other 5.3%
Who owns ADMA Biologics stock?
Institutional investors own about 92.8% of ADMA Biologics's shares, spread across 438 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.97% of ADMA.
The largest institutional holders are Blackrock Inc. (17.12%), State Street Corporation (7.64%) and Vanguard Capital Management LLC (4.51%). Together, the top 10 institutions control 53.0% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their ADMA positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ADMA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 38.36M | 17.12% | +4.1% |
| State Street Corporation | 17.12M | 7.64% | +21.5% |
| Vanguard Capital Management LLC | 10.10M | 4.51% | -2.0% |
| Vanguard Portfolio Management LLC | 10.09M | 4.50% | +13.8% |
| Rubric Capital Management LP | 9.34M | 4.17% | +416.2% |
| Capital Research Global Investors | 8.76M | 3.91% | -21.8% |
| First Trust Advisors LP | 7.80M | 3.48% | +2064.9% |
| Geode Capital Management, LLC | 6.06M | 2.71% | +4.0% |
| Caligan Partners, LP | 5.73M | 2.56% | +20.4% |
| Shaw D.E. & Co., Inc. | 5.27M | 2.35% | +840.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ADMA
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 14.11M | 6.30% |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 9.97M | 4.45% |
| SmallCap World Fund Inc | 8.52M | 3.81% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 8.20M | 3.66% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 7.02M | 3.14% |
| iShares Trust-iShares Russell 2000 ETF | 5.90M | 2.63% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 2.66M | 1.19% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.52M | 1.13% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 2.52M | 1.13% |
| iShares Trust-iShares S&P Small-Cap 600 Growth ETF | 2.20M | 0.98% |
Frequently asked questions
Who is the largest shareholder of ADMA Biologics?
Blackrock Inc. is the largest institutional shareholder of ADMA, owning 17.12% of shares outstanding (38.36M shares) as of its latest 13F filing.
What percentage of ADMA Biologics is owned by institutions?
Institutions own about 92.8% of ADMA shares and 94.6% of the public float.
How much of ADMA Biologics do insiders own?
Insiders, such as officers and directors, own about 1.97% of ADMA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.